Navigation Links
NimbleGen to discontinue IPO after Roche's $272.5 million acquisition

Madison, Wis. - NimbleGen Systems, a manufacturer of gene chips for pharmaceutical research, will discontinue its work toward an initial public offering of stock following its acquisition by Roche, the Basel, Switzerland based pharmaceutical giant.

NimbleGen had sought to raise $75 million in the IPO, but und......

Full article >>> ich reported $13.5 million in revenue last year, was spun out of the University of Wisconsin-Madison and has reached this point with the help of venture funding from firms like Baird Venture Partners and Venture Investors. The company pursued an IPO in pa......

Full article >>> potential drug targets.

In addition, NimbleGen plans to expand its product portfolio to include higher-density arrays and integrated instrument systems for advanced genome analysis.

Roche milestone

In 2006, the Roche pharmaceuticals division reported sales of 33.3 billion Swiss francs, and the diagnostics division posted sales of 8.7 billion Swiss francs. The com......

Full article >>> xciting" development for the state's biotechnology industry, noting that state officials have been trying to attract a global pharmaceutical company.

Leonhart cited the state's courting of Abbott Labs, which has acquired 500 acres of land in the Kenosha County communities of Pleasant Prairie and Bristol, but has yet to officially announce whether i......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 06/19/07


Related biology technology :

1. NimbleGen researcher to lead $415K DNA project
2. IPO-bound NimbleGen traveling in fast company
3. Madison biotech NimbleGen files for IPO; one of states best-funded firms
4. Genomics researcher Hood joins NimbleGen board
5. NimbleGen partners with UK biotech firm
6. NimbleGen extends research market reach
7. NimbleGen microarrays speed genetic findings
8. NimbleGen names CFO with capital-raising past
9. NimbleGen partners with leading researchers
10. NimbleGen closes $8.2m venture round, bringing total to $50m
11. NimbleGen Systems CGS technique helps identify stomach bacteria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/4/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the ... Edward Lanphier , Sangamo,s president and chief executive officer, ... ZFP Therapeutic ® development programs and an overview ... on Thursday, February 11, 2016, at the Leerink Partners ... is being held in New York ...
(Date:2/4/2016)... 4, 2016 Beike Biotechnology, the ... attended a ceremony in late 2015 to mark their ... in 2016. --> --> ... for Personalized Cell Therapy" was hosted by the Shenzhen ... both subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... YORK , February 4, 2016 ... QBIO), a biotechnology acceleration company is pleased to provide the ... --> Over the last 3 months we ... and securities purchase agreements exceeding $1,000,000. As a result, we ... our Mannin Research Inc. license agreement and expect that development ...
(Date:2/4/2016)... -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... in China , today announced that ... on February 4, 2016 a preliminary non-binding proposal letter, ... PKU V-Ming ( Shanghai ) Investment Holdings ... ( Shenzhen ) Fund Management Co., Ltd., ...
Breaking Biology Technology:
(Date:1/15/2016)... Puerto Rico , Jan. 15, 2016 ... big and small to find new ways to ensure ... culture. iOS and Android ... based on biometrics, transforming it into a hardware authorization ... that users swipe their fingerprint on their KodeKey enabled ...
(Date:1/11/2016)... , Jan. 11, 2016  higi, the leading ... 10,000 retail locations, web and mobile, today announced ... million from existing investors. --> ... devoted to further innovate higi,s health platform – ... web portal – including expanding services and programs ...
(Date:1/7/2016)... , Jan. 7, 2016 Various ... for biopharmaceutical products such as biologics and biosimilars. ... to reduce healthcare expenditure, growing demand for cost-effective ... aging population. Biosimilars are similar versions of their ... regards to their quality, safety, and efficacy. The ...
Breaking Biology News(10 mins):